Last reviewed · How we verify
NCT06958380
Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study
NA trial testing Corrective exercise and rehabilitation in Fanconi Anemia in 1 participant. Completed in 20 July 2025.
2 July 2025
Quick facts
| Lead sponsor | Pardis Specialized Wellness Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 1 |
| Start date | 3 May 2025 |
| Primary completion | 2 July 2025 |
| Estimated completion | 20 July 2025 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Corrective exercise and rehabilitation
Conditions studied
- Fanconi Anemia — all drugs for Fanconi Anemia →
Sponsor
Pardis Specialized Wellness Institute
Who can join
18 and older, male only, with Fanconi Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Fanconi anemia (FA) is a rare autosomal recessive DNA repair disorder characterized by congenital malformations, progressive bone marrow failure, and reduced quality of life. Although physical and occupational therapy are routinely recommended to address skeletal anomalies in FA, no studies have evaluated the impact of a structured corrective exercise and rehabilitation program on patient outcomes. Method: In this single case clinical report, an adult FA patient will complete a 12 week supervised corrective exercise and rehabilitation program (36 sessions; 3 × 40-45 min/week) delivered via in-person supervised sessions. Primary outcome is change in patient reported quality of life (SF 36) from baseline to week 12; secondary outcomes include muscle strength, fatigue severity, postural parameters, and hematological indices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06958380
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fanconi Anemia
Currently open trials in the same condition.
- NCT06744283 — Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia · recruiting
- NCT05687149 — Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia · recruiting
- NCT05973656 — Role of Acetaldehyde in the Development of Oral Cancer · NA · recruiting
- NCT04437771 — Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy · active not recruiting
- NCT04232085 — Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failu · Phase 2 · recruiting
Other Pardis Specialized Wellness Institute trials
Trials by the same sponsor.
- NCT07525973 — The Effect of Eye Exercises on Motor Performance, Balance, and Fall Risk in Parkinson's Disease · NA · not yet recruiting
- NCT07264114 — Aquatic High-Intensity Interval Training for Parkinson's Disease · NA · active not recruiting
- NCT07000006 — The Effect of Exercise on Low Back Pain in Peritoneal Dialysis Patients · NA · completed
- NCT06877962 — The Effect of Home-based Exercise on Postural Abnormalities · NA · completed
- NCT06787599 — The Effect of Home Based Tele-Exercise on Peritoneal Dialysis Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06958380 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pardis Specialized Wellness Institute
- Last refreshed: 12 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06958380.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing